FDA Panel Votes for Removal of Drug Meant to Prevent Preterm Births
WEDNESDAY, Oct. 19, 2022 -- A U.S. Food and Drug Administration advisory committee on Wednesday voted to recommend that a controversial drug meant to prevent premature births be pulled from the market. FDA officials have said they want to withdraw... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 19, 2022 Category: Pharmaceuticals Source Type: news

FDA Panel Votes for Removal of Makena Meant to Prevent Preterm Births
WEDNESDAY, Oct. 19, 2022 -- A U.S. Food and Drug Administration advisory committee on Wednesday voted to recommend that a controversial drug meant to prevent premature births be pulled from the market. FDA officials have said they want to withdraw... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 19, 2022 Category: Pharmaceuticals Source Type: news

FDA Panel Recommends Pulling Preterm Birth Drug From the Market
The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective. (Source: NYT Health)
Source: NYT Health - October 19, 2022 Category: Consumer Health News Authors: Christina Jewett Tags: Babies and Infants Pregnancy and Childbirth Premature Babies Drugs (Pharmaceuticals) Regulation and Deregulation of Industry Food and Drug Administration Source Type: news

Drug meant to prevent premature births should be removed from market, FDA panel says
An FDA panel recommends that a drug approved to prevent premature birth be removed from the market because it doesn't work and carries risks. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - October 19, 2022 Category: Science Authors: Melody Petersen Source Type: news

FDA Panel Votes for Removal of Drug Meant to Prevent Preterm Births
WEDNESDAY, Oct. 19, 2022 -- A U.S. Food and Drug Administration advisory committee on Wednesday voted to recommend that a controversial drug meant to prevent premature births be pulled from the market. FDA officials have said they want to withdraw... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 19, 2022 Category: General Medicine Source Type: news

FDA Panel Backs Removal of Unproven Pregnancy Drug
WASHINGTON — Federal health advisers have concluded that a drug intended to prevent premature births hasn’t been shown to work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market. The Food and Drug Administration’s advisory panel voted 14-1 Wednesday that the injectable drug Makena should be withdrawn, despite appeals from the manufacturer to keep it available pending additional research. The experts essentially agreed with a 2020 FDA decision that deemed the drug ineffective and called for its removal. The manufacturer, Covis Pharma, had challenged th...
Source: TIME: Health - October 19, 2022 Category: Consumer Health News Authors: Matthew Perrone/AP Tags: Uncategorized Drugs healthscienceclimate wire Source Type: news

FDA panel backs removal of unproven pregnancy drug
A panel of federal advisers says a pregnancy drug intended to prevent premature births should be withdrawn because it doesn't work (Source: ABC News: Health)
Source: ABC News: Health - October 19, 2022 Category: Consumer Health News Tags: Health Source Type: news

FDA panel votes to pull only drug approved to prevent premature births
A leading FDA panel has voted to pull the premature birth drug Makena from the market by a 14-1 vote. It is likely that the agency will follow by removing it from shelves in the coming days. (Source: the Mail online | Health)
Source: the Mail online | Health - October 19, 2022 Category: Consumer Health News Source Type: news

UC Davis Children's Hospital neonatal doctors to aid St. Joseph's Medical Center NICU in Stockton
UC Davis Children ’s Hospital has a new partnership with a San Joaquin County hospital, aimed at preventing more premature babies and their parents from needing to come to Sacramento for medical treatment. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 19, 2022 Category: American Health Authors: Emily Hamann Source Type: news

FDA could pull only drug to prevent premature births
The FDA could soon pull the only available drug believed to prevent premature birth after a 2019 study found that it was not effective. The company is fighting the move this week. (Source: the Mail online | Health)
Source: the Mail online | Health - October 18, 2022 Category: Consumer Health News Source Type: news

Makena Focus of FDA, Company Square Off
TUESDAY, Oct. 18, 2022 -- In a three-day hearing that began Monday, a U.S. Food and Drug Administration advisory committee will give the maker of a drug meant to prevent premature births a chance to show why its drug should not be pulled off the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 18, 2022 Category: Pharmaceuticals Source Type: news

FDA, Company Square Off in Hearing Over Drug Makena, Meant to Prevent Preterm Births
MONDAY, Oct. 17, 2022 -- In a three-day hearing that began Monday, a U.S. Food and Drug Administration advisory committee will give the maker of a drug meant to prevent premature births a chance to show why its drug should not be pulled off the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 17, 2022 Category: General Medicine Source Type: news

FDA pushes to remove pregnancy drug, company pushes back
The maker of a drug intended to reduce premature births is making a last-ditch effort to keep its medication on the market, even as health regulators insist that it doesn’t work (Source: ABC News: Health)
Source: ABC News: Health - October 17, 2022 Category: Consumer Health News Tags: Health Source Type: news

Lucy Letby trial: Nurse killed baby and sent parents card, trial told
Lucy Letby tried repeatedly to kill the premature baby girl before succeeding, her murder trial hears. #lucyletby #murdertrial #baby #nurse #babygirl (Source: Reuters: Health)
Source: Reuters: Health - October 12, 2022 Category: Consumer Health News Source Type: news

When Should a Newborn Infant Start Tummy Time?
Discussion Tummy time (TT) is one of a newborn’s and young infant’s major physical activities. TT is when an infant is placed awake on a firm surface (such as a floor) in a prone position while supervised by an adult. This encourages the infant to elevate their head and push up with arms to elevate their upper torso. TT is encouraged to be done in short amounts of time several times a day and to increase the amount of time in this supervised position up to 30 minutes total per day. TT has been associated with gross motor movement and development and is a component of the World Health Organization’s and se...
Source: PediatricEducation.org - October 10, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news